Printer Friendly

MOORE MEDICAL REPORTS HIGHER EARNINGS IN THE THIRD QUARTER

 MOORE MEDICAL REPORTS HIGHER EARNINGS IN THE THIRD QUARTER
 NEW BRITAIN, Conn., Oct. 21 /PRNewswire/ -- Moore Medical Corp. (AMEX: MMD), today reported sales of $65,010,000 for the third quarter ending Sept. 26, 1992, compared with $73,887,000 for last year's third quarter. Net income for the quarter of $937,000 (33 cents per share) increased significantly over the $239,000 (8 cents per share) earned in the comparable 1991 quarter. Before an extraordinary tax benefit, income per share was 23 cents in the 1992 quarter compared with 5 cents in the prior year's quarter.
 Commenting on the quarter, Mark E. Karp, president and chief executive officer, stated "Our decision to not sell brand name pharmaceuticals at unacceptably low margins has resulted in lower overall sales this year. However, our profits have improved as sales13 perce nt n the third quarter, a level substantially higher than achieved in recent years. Operating expenses are appropriate for the current business mix and interest expense is down as the result of more favorable interest rates and lower debt levels.
 These developments this year are in accordance with the strategic redirection of the business we adopted last year. We have further opportunities to improve future performance as we progressively cultivate broadened customer loyalty in the value added areas of our business."
 Moore Medical Corp. is a national wholesale distributor of brand name and generic pharmaceuticals and medical and surgical supplies.
 MOORE MEDICAL CORPORATION
 Comparative Results of Operations
 For The Third Quarters Ended
 Sept. 26, 1992 and Sept. 28, 1991
 (In thousands, except per share data)
 Percent Pct. of Sales
 1992 1991 Change 1992 1991
 Net sales $65,010 $73,887 (12) 100.0 100.0
 Cost of products
 sold 56,532 65,643 (14) 87.0 88.8
 Gross profit 8,478 8,244 3 13.0 11.2
 Selling, general
 & administrative
 expenses 6,862 6,869 --- 10.5 9.3
 Operating income 1,616 1,375 18 2.5 1.9
 Interest expense, net 642 1,117 (43) 1.0 1.5
 Income before income
 taxes and
 extraordinary item 974 258 278 1.5 .4
 Income tax provision 330 107 --- .5 .2
 Income before
 extraordinary item 644 151 --- 1.0 .2
 Extraordinary item-(a) 293 88 --- .4 .1
 Net income $937 $239 292 1.4 .3
 Income per share:
 Income before
 extraordinary item 23 cents 5 cents
 Net income 33 cents 8 cents
 Average shares
 outstanding 2,860 2,846
 ----
 Note (a): Extraordinary item reflects tax benefits from utilization
 of net operating loss carryforwards.
 Comparative Results of Operations
 For the First Three Quarters Ended
 Sept. 26, 1992 and Sept. 28, 1991
 (In thousands, except per share data)
 Percent Pct. of Sales
 1992 1991 Change 1992 1991
 Net sales $211,319 $242,498 (13) 100 100
 Cost of products sold 185,799 217,131 (14) 87.9 89.5
 Gross profit 25,520 25,367 -- 12.1 10.5
 Selling, general &
 administrative expenses 20,595 21,047 (2) 9.8 8.7
 Operating income 4,925 4,320 14 2.3 1.8
 Interest expense, net 2,322 3,613 (36) 1.1 1.5
 Income before income
 taxes and
 extraordinary item 2,603 707 268 1.2 .3
 Income tax provision 928 307 -- .4 .1
 Income before
 extraordinary item 1,675 400 -- .8 .2
 Extraordinary item-(a) 798 240 -- .4 .1
 Net income $2,473 $640 286 1.2 .3
 Income per share:
 Income before
 extraordinary item 59 cents 14 cents
 Net income 87 cents 22 cents
 Average shares
 outstanding 2,851 2,847
 ----
 Note(a): Extraordinary item reflects tax benefits from utilization of net operating loss carryforwards.
 -0- 10/21/92
 /CONTACT: John A. Murray of Moore Medical Corp., 203-826-3677/
 (MMD) CO: Moore Medical Corp. ST: Connecticut IN: HEA MTC SU: ERN


TM -- NE020 -- 3151 10/21/92 17:14 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1992
Words:641
Previous Article:SWEET SUE KITCHENS ANNOUNCES VOLUNTARY RECALL OF 'MIXING CHICKEN IN BROTH' IN TEXAS AND GEORGIA
Next Article:S&P'S STOCK PRICE INDEX -- CLOSING, WEDNESDAY, OCT. 21/PRN/
Topics:


Related Articles
MOORE MEDICAL REPORTS THIRD QUARTER RESULTS
MOORE MEDICAL REPORTS EARNINGS IMPROVEMENT IN SECOND QUARTER
IMCERA REPORTS SIGNIFICANT INCREASE IN FISCAL 1993 FIRST QUARTER EARNINGS FROM CONTINUING OPERATIONS
MOORE MEDICAL REPORTS 300 PERCENT EARNINGS INCREASE FOR 1992 AND FOURTH QUARTER
IMCERA DISCUSSES REVIEW OF PITMAN-MOORE OPERATIONS; REVISES THIRD QUARTER AND FULL YEAR EPS EXPECTATIONS DUE TO PITMAN-MOORE PERFORMANCE
MOORE MEDICAL REPORTS HIGHER EARNINGS IN FIRST QUARTER
MOORE MEDICAL ANNOUNCES RESULTS FOR 1994 AND FOURTH QUARTER
MOORE MEDICAL ANNOUNCES THIRD QUARTER RESULTS
Moore Medical Reports Strong Third Quarter Results Earnings in Period Increase 25% Over 1996
Moore Medical Achieves Highest Quarterly Earnings in Over 10 Years.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters